“…However, in light of the current prescription opioid epidemic, we recently changed our focus to studying relapse to oxycodone, a prototypical prescription opioid drug that is widely used for pain management (Van Zee, 2009;Yaksh & Wallace, 2011). We also chose to study oxycodone because compared to heroin (Wise, 1989;Koob, 1992;Badiani et al, 2011;Bossert et al, 2013), there are very few published studies on oxycodone self-administration and relapse/reinstatement (Leri & Burns, 2005;Campbell et al, 2012;Pravetoni et al, 2014;Secci et al, 2016;Neelakantan et al, 2017;Townsend et al, 2017;You et al, 2017). Human and rodent binding studies show that oxycodone is a preferential mu opioid receptor (MOR) agonist (Lalovic et al, 2006;Peckham & Traynor, 2006) with lower affinity to MOR than morphine (Lalovic et al, 2006;Peckham & Traynor, 2006); there is also evidence that oxycodone binds to the kappa opioid receptor (KOR) (Nielsen et al, 2007).…”